Childrens hospital of LA

Los Angeles, California 90033

0 studies enrolling now · 10 studies all time

What they study most

Acute Lymphoblastic Leukemia, Adenovirus Disease, Cystic Fibrosis, Double-stranded DNA Virus, Hemophilia A, Kidney Transplant, Leukemia, Pediatric, Lymphoma, Malignant Melanoma, Neuroblastoma, Outcomes, Survival Rates

Studies at this site

• A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase — Completed
• Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia — Completed
• Study to Assess Brincidofovir Treatment of Serious Diseases or Conditions Caused by Double-stranded DNA Viruses — Completed
• Phase 2 Study to Evaluate Brincidofovir for the Prevention of Adenovirus Disease — Completed
• Study of Emicizumab Prophylaxis in Participants With Hemophilia A With or Without Inhibitors Undergoing Minor Surgical Procedures — Stopped early
• The Chimerix CMX001 Registry — Stopped early
• Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma — Stopped early
• Pharmacokinetics, Safety and Tolerability of Single-dose Belatacept in Adolescent Kidney Transplant Recipients — Completed
• A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC) — Stopped early
• Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma — Withdrawn before enrolling